Clinic
Valley Regional Enterprises, INC
Valley Regional Enterprises, INC was paid $8.57M by Medicaid between Jan 2018 and Dec 2024, across 43 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.
33Billing provider infoVALLEY REGIONAL ENTERPRISES, INC
WINCHESTER, VA 22601
WINCHESTER, VA 22601
33aNPI1235178591assigned 06/05/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$8.57M
24GClaims235,250
24DCodes billed43
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Virginia
Rank by total paid#6 of 51
Median peer was paid$182K
This provider vs. median47×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CHAMBERS, JILL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,121 | $624K | |
| 2019 | 26,770 | $1.10M | |
| 2020 | 19,310 | $891K | |
| 2021 | 26,658 | $1.18M | |
| 2022 | 51,842 | $1.55M | |
| 2023 | 54,261 | $1.65M | |
| 2024incomplete | 41,288 | $1.56M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 39% | 44,262 | 40,580 | $3.34M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 40,938 | 38,253 | $2.39M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.4% | 11,098 | 10,662 | $802K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.1% | 4,936 | 4,711 | $523K |
| 87428 | 6.0% | 15,418 | 14,693 | $516K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.8% | 26,013 | 24,412 | $325K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 15,382 | 7,241 | $187K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 5,615 | 5,348 | $153K |
| 87430 | 1.6% | 11,031 | 10,481 | $138K | |
| 3074F | <1% | 14,040 | 13,089 | $35K | |
| 3078F | <1% | 13,019 | 12,169 | $31K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,254 | 1,194 | $29K |
31 more codes
| 3079F | <1% | 5,147 | $13K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 81 | $9K |
| 3077F | <1% | 3,226 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 521 | $7K |
| 81003 | <1% | 3,676 | $6K | |
| 3075F | <1% | 2,971 | $6K | |
| 94760 | <1% | 7,160 | $5K | |
| 3080F | <1% | 2,121 | $5K | |
| 87807 | <1% | 373 | $5K | |
| 80047 | <1% | 518 | $4K | |
| 99000 | <1% | 3,303 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 99 | $4K |
| 73610 | <1% | 139 | $4K | |
| 85027 | <1% | 595 | $3K | |
| 73630 | <1% | 128 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 68 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 56 | $3K |
| 93000 | <1% | 193 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 141 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 690 | $1K |
| 81025 | <1% | 123 | $762.24 | |
| 73110 | <1% | 14 | $486.21 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $438.56 |
| 29125 | <1% | 12 | $437.35 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 87 | $261.07 |
| 81002 | <1% | 89 | $233.44 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 531 | $90.79 |
| 99051 | <1% | 47 | $41.25 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 90 | $24.72 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $18.10 |
| 36416 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAMBERS, JILL (MANAGER INSURANCE CREDENTIALING)
Parent organizationVALLEY REGIONAL ENTERPRISES, INC
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.